Patanjali's packet milk to be lower than competitor brands by Rs 2 a litre
Let's look at the major provisions that will have lasting effect on the industry, both domestic and exports.
On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.
'When you come through the hassles and struggles of business life, your mind is wired differently.' 'You are more connected to reality,' Akali Dal MP Naresh Gujral tells Rahul Jacob and Archis Mohan
Sitharaman, who is not known to reply to comments made on her Twitter handle, instantly choose to respond to drug-maker Biocon chairman Kiran Mazumdar-Shaw's criticism of lack of fiscal measures to support growth.
Pharma major Wockhardt said on Thursday that it had achieved a breakthrough in the development of Glargine, a new generation advanced insulin
The past eight months have seen vast improvement in the Indian economy, says Edelweiss Group chairman and chief executive Rashesh Shah, who feels domestic-oriented sectors are likely to do better.
The report said that India maintains zero-tolerance standards for certain plant quarantine pests, such as weed seeds and ergot.
Fresh guidelines issued by the Union home ministry on Wednesday permit industries operating in rural areas to run from April 30 with strict social distancing norms.
PM said he admires German leadership in clean energy and commitment to combating climate change.
Industry body Assocham on Tuesday said the Indian pharma industry would grow at 11 per cent to touch Rs 60,000 crore (Rs 600 billion) in 2007-08 from Rs 39,000 crore (Rs 390 billion) in 2003-04, when drugs worth $65 billion would go off patent.
Inspections only in domestic authorities' presence, visiting US drug regulator told
India's exports to China stood at $7.56 billion during the period whereas the imports have jumped to $52.26 billion in April-January
Employees asked to work from home... cancelled travel plans... curtailed meetings... Caution and precaution dominate Corporate India's response to Covid-19.
In containment areas, movements of people is totally banned and essential services are delivered at the doorsteps.
Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.
'The story ends at the end of this season; I don't know if they will extend it. It's a fairly solid conclusion (but) there is always scope for more.'
India's GDP growth for the current fiscal is expected to slow down to 4.8 per cent, a UN report has said, warning that the Covid-19 pandemic is expected to result in significant adverse economic impacts globally. The UN 'Economic and Social Survey of Asia and the Pacific (ESCAP) 2020: Towards sustainable economies' said that Covid-19 is having far-reaching economic and social consequences for the region, with strong cross-border spillover effects through trade, tourism and financial linkages.
Better-than-expected financial results in Q3 due to higher revenue growth and margins in key markets fuel the rally
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
4 Ranbaxy facilities in India have been barred from exporting to US.
.jpg)
India has been pursuing measures that discriminate against overseas businesses, says US Congressman Erik Paulsen.
Nifty50 surged 145 points to close at 8,468 after hitting an intra-day high of 8,475.
According to the chairman, there will be an annual loss of Rs 100 crore due to the MHRA alert on Waluj plant
Investors will maintain a cautious stance.
From scanning hospital entrants to disinfecting hospital areas and floors, robots are being roped in for tasks considered high-risk, says Peerzada Abrar.
We present here glimpse of toy manufacturing factories from around the globe.
The company has received a communication from the Medicines and Healthcare Products Regulatory Agency, United Kingdom, whereby the agency has decided to withdraw the previously issued GMP Certificate to the company's manufacturing facility situated at Kadaiya, Nani Daman, Wockhardt said in a filing to the Bombay Stock Exchange.
Three stockmarket experts give their best picks for the New Year.
Kerry is scheduled to head to India later this month for the fourth annual US-India Strategic Dialogue.
With EU, it is part of the FTA that we will need to negotiate.
The two sides signed a maritime security agreement after extensive talks between Prime Minister Narendra Modi and his Mauritian counterpart Pravind Jugnauth.
Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.
Ranbaxy Laboratories on Wednesday reported widening of its consolidated net loss to Rs 1,029.72 crore (Rs 10.29 billion) for the third quarter ended December 31, 2014
Experts say the stock market correction in recent times increases the risk-reward in favour of large-cap stocks.
"We have received complaint from a state yesterday and so far discussed with three states. Too much variations have been reported in results of rapid test kits and RT-PCR kits. We advise states not to use them for the next two days," ICMR's Dr Raman R Gangakhedkar said.
The rupee recovered from more-than three months low of 63.15 in early trade on dollar selling by banks.
'Mucor is an environmental fungus, and it's much more prevalent in hot and humid areas.' 'The amount of fungus in the air is much higher in India than some other parts of the world.'
